Results 1 to 2 of 2

Thread: Lupus Drug BenlystaŽ (belimumab) Priority Review Granted By FDA

  1. #1
    Join Date
    Nov 2009
    Posts
    150
    Thanks
    0
    Thanked 20 Times in 13 Posts

    Default Lupus Drug BenlystaŽ (belimumab) Priority Review Granted By FDA

    BenlystaŽ (belimumab), a potential treatment for systemic lupus erythematosus has been granted a priority review designation by the FDA (Food and Drug Administration, USA), which is granted to medications, that if approved, offer significant treatment advances or provide treatment when no proper therapy exists...

    More...

  2. #2
    Join Date
    Mar 2009
    Location
    NJ
    Posts
    492
    Blog Entries
    1
    Thanks
    30
    Thanked 53 Times in 49 Posts

    Default

    "The FDA has assigned belimumab a Prescription Drug User Fee Act (PDUFA) target date of December 9, 2010."

    Does this mean that it will possibly be available then?
    Lauren

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •